Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Horne

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Vaccine|February 18, 2026
Effectiveness of bivalent BA.1 mRNA booster vaccines during the autumn 2022 COVID-19 booster programme in adults aged 50+ in England: observational matched cohort study using OpenSAFELYPaul Madley-Dowd, Elsie M F Horne, William J Hulme, et al.
American Journal of Clinical Oncology|December 1, 2005
Comparison of treatment volumes and techniques in prostate cancer radiation therapyCatherine T Lee, Lei Dong, Anesa W Ahamad, et al.
The Lancet Regional Health. Europe|June 26, 2023
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study, Edward P K Parker, Elsie M F Horne, et al.
American Journal of Epidemiology|September 1, 2023
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLANDElsie M F Horne, William J Hulme, Ruth H Keogh, et al.
Neurology|April 27, 2023
Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral TherapyCynthia McMahan, Devon K Dietrich, Elizabeth F Horne, et al.
BMJ (Clinical Research Ed.)|March 15, 2023
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPPWilliam J Hulme, Elsie M F Horne, Edward P K Parker, et al.
Epidemiology (Cambridge, Mass.)|June 24, 2024
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPPElsie M F Horne, William J Hulme, Edward P K Parker, et al.
JAMA Psychiatry|August 21, 2024
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated PeopleVenexia M Walker, Praveetha Patalay, Jose Ignacio Cuitun Coronado, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2024
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million peopleKurt Taylor, Sophie Eastwood, Venexia Walker, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|February 18, 2026
Effectiveness of bivalent BA.1 mRNA booster vaccines during the autumn 2022 COVID-19 booster programme in adults aged 50+ in England: observational matched cohort study using OpenSAFELYPaul Madley-Dowd, Elsie M F Horne, William J Hulme, et al.
American Journal of Clinical Oncology|December 1, 2005
Comparison of treatment volumes and techniques in prostate cancer radiation therapyCatherine T Lee, Lei Dong, Anesa W Ahamad, et al.
The Lancet Regional Health. Europe|June 26, 2023
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study, Edward P K Parker, Elsie M F Horne, et al.
American Journal of Epidemiology|September 1, 2023
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLANDElsie M F Horne, William J Hulme, Ruth H Keogh, et al.
Neurology|April 27, 2023
Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral TherapyCynthia McMahan, Devon K Dietrich, Elizabeth F Horne, et al.
BMJ (Clinical Research Ed.)|March 15, 2023
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPPWilliam J Hulme, Elsie M F Horne, Edward P K Parker, et al.
Epidemiology (Cambridge, Mass.)|June 24, 2024
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPPElsie M F Horne, William J Hulme, Edward P K Parker, et al.
JAMA Psychiatry|August 21, 2024
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated PeopleVenexia M Walker, Praveetha Patalay, Jose Ignacio Cuitun Coronado, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2024
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million peopleKurt Taylor, Sophie Eastwood, Venexia Walker, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
Pageof 3